Revenue optimization platform for biopharma commercialization and pricing
IntegriChain operates a data-driven commercialization platform serving biopharma manufacturers on pricing, market access, and net revenue optimization. The tech stack—Python, SQL Server, Snowflake, dbt, AWS, and RPA tools (UiPath)—reflects a company automating labor-intensive healthcare data workflows while migrating toward cloud-native architecture. Active hiring across engineering, data, and ops roles, paired with projects spanning pricing frameworks, Medicaid rebate calculations, and chargeback reconciliation, signals ongoing investment in compliance automation and channel data visibility.
IntegriChain provides revenue optimization technology and consulting services to pharmaceutical manufacturers navigating complex drug-access economics. The core product, ICyte, combines SaaS, business-process-as-a-service, and consulting to connect commercial, financial, and operational dimensions of drug distribution—from demand planning through net revenue realization. The company operates across three lines: software and analytics (data pipelines, pricing models, forecasting), outsourced services (handling high-volume healthcare data processing), and consulting on market access strategy. Backed by Nordic Capital, IntegriChain has grown to 501–1,000 employees across offices in Philadelphia and Ambler (Pennsylvania) and Pune (India).
Python, SQL Server, Snowflake, dbt, AWS (RDS, CodePipeline), Oracle, PostgreSQL, Salesforce, UiPath (Studio and Orchestrator), Docker, Kubernetes, Terraform, and CI/CD tools including GitHub Actions, Jenkins, and CircleCI.
Current projects include cloud migration, government pricing compliance (Medicaid rebate calculations), data pipeline and enrichment work, pricing and forecasting analytics, RPA-based automation, and chargeback reconciliation systems.
Other companies in the same industry, closest in size